Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-κB

American Journal of Chinese Medicine

Volumn 40, Issue 1, 2012, Pages 187-202

  Hwang, Jeong Won ^a   Oh, Jung Han ^b   Yoo, Hwa Seung ^b   Lee, Yeon Weol ^b   Cho, Chong Kwan ^b   Kwon, Ki Rok ^c   Yoon, Jung Ho ^d   Park, Junsoo ^d   Her, Song ^a   Lee, Zee Won ^a   Jang, Ik Soon ^a   Choi, Jong Soon ^a,e  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Daejeon University   (South Korea)

^c Pharmacopuncture Medical Research Institute   (South Korea)

^d Yonsei University Wonju   (South Korea)

^e Chungnam National University   (South Korea)

Author keywords

Butanol Extracted Mountain Ginseng; Lung Cancer; Nuclear Factor kappa B

Indexed keywords

BUTANOL; CASPASE 3; GINSENG EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RE; GINSENOSIDE RG 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MOUNTAIN GINSENG EXTRACT; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; SOLVENT EXTRACTION; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GINSENOSIDES; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; NF-KAPPA B; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863022493     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500152     Document Type: Article

References (34)

1. Cai, B.X., S.L. Jin, D. Luo, X.F. Lin and J. Gao. Ginsenoside Rb1 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Biol. Pharm. Bull. 32: 837-841, 2009.
2. Chang, Y.H. and P.K. Ng. Effects of extrusion process variables on extractable ginsenosides in wheat-ginseng extrudates. J. Agric. Food Chem. 57: 2356-2362, 2009.
3. Chen, X., K. Kandasamy and R.K. Srivastava. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res. 63: 1059-1066, 2003. (Pubitemid 36278439)
4. Chung, V.Q., M. Tattersall and H.T. Cheung. Interactions of an herbal combination that inhibits growth of prostate cancer cells. Cancer Chemother. Pharmacol. 53: 384-390, 2004. (Pubitemid 38553659)
5. Garg, A.K., G.N. Hortobagyi, B.B. Aggarwal, A.A. Sahin and T.A. Buchholz. Nuclear factor-KB as a predictor of treatment response in breast cancer. Curr. Opin. Oncol. 15: 405-411, 2003. (Pubitemid 38147034)
6. Gilmore, T.D. Introduction to NF-KB: players, pathways, perspectives. Oncogene 25: 6680-6684, 2006. (Pubitemid 44657845)
7. Jang, H.I. and H.M. Shin. Wild Panax ginseng (Panax ginseng CA. Meyer) protects against methotrexate-induced cell regression by enhancing the immune response in RAW 264.7 macrophages. Am. J. Chin. Med. 38: 949-960, 2010.
8. Jemal, A., R. Siegel, E. Ward, Y. Hao, J. Xu and M.J. Thun. Cancer statistics. CA Cancer J. Clin. 59: 225-249, 2009.
9. Johnson, T.E., D. Hermanson, L. Wang, F. Kassie, P. Upadhyaya, M.G. O'Sullivan, S.S. Hecht, J. Lu and C. Xing. Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice. Am. J. Chin. Med. 39: 727-742, 2011.
10. Karin, M. and F.R. Greten. NF-KB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5: 749-759, 2005. (Pubitemid 41400849)
11. Kluck, R.M., E. Bossy-Wetzel, D.R. Green and D.D. Newmeyer. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997. (Pubitemid 27097313)
12. Koo, H.N., H.J. Jeong, I.Y. Choi, H.J. An, P.D. Moon, S.J. Kim, S.Y. Jee, J.Y. Um, S.H. Hong, S.S. Shin, D.C. Yang, Y.S. Seo and H.M. Kim. Mountain grown ginseng induces apoptosis in HL-60 cells and its mechanism have little relation with TNF-a production. Am. J. Chin. Med. 35: 169-182, 2007.
13. Kuo, P.C., H.F. Liu and J.I. Chao. Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells. J. Biol. Chem. 279: 55875-55885, 2004.
14. Lee, B.L., H.S. Lee, J. Jung, S.J. Cho, HY. Chung, W.H. Kim, Y.W. Jin, C.S. Kim and S.Y. Nam. Nuclear factor-KB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin. Cancer Res. 11: 2518-2525, 2005. (Pubitemid 40569448)
15. Lee, J.H., K.R. Kwon, C.K. Cho, S.S. Han and H.S. Yoo. Advanced cancer cases treated with cultivated wild ginseng phamacopuncture. J. Acup. Mer. Stu. 3: 119-124, 2010.
16. Lin, CF., KL. Wong, R.S. Wu, T.C. Huang and C.F. Liu. Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity. Phytother. Res. 17: 1119-1122, 2003. (Pubitemid 37351594)
17. Liu, T.G., Y. Huang, D.D. Cui, X.B. Huang, S.H. Mao, L.L. Ji, H.B. Song and C. Yi. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 9: 250, 2009.
18. Luo, J.L., S. Maeda, L.C. Hsu, H. Yagita and M. Karin. Inhibition of NF-KB in cancer cells converts inflammation-induced tumor growth mediated by TNFa to TRAIL-mediated tumor regression. Cancer Cell 6: 297-305, 2004. (Pubitemid 39222042)
19. Mohamad, N., A. Gutierrez, M. Nunez, C Cocca, G. Martin, G. Cricco, V. Medina, E. Rivera and R. Bergoc. Mitochondrial apoptotic pathways. Biocell 29: 149-161, 2005. (Pubitemid 41297442)
20. Mow, B.M., AL. Blajeski, J. Chandra and S.H. Kaufmann. Apoptosis and the response to anticancer therapy. Curr. Opin. Oncol. 13: 453-462, 2001. (Pubitemid 33027897)
21. Pal, S.K., RA. Figlin and K.L. Reckamp. The role of targeting mammalian target of rapamycin in lung cancer. Clin. Lung Cancer 9: 340-345, 2008.
22. Park, S.M., M. Chae, B.K. Kim, T. Seo, I.S. Jang, J.S. Choi, I.C Kim, J.H. Lee and J. Park. SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2. Biochem. Biophys. Res. Commun. 391: 926-930, 2010.
23. Park, W.H., S.K. Lee and C.H. Kim. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats. Life Sci. 76: 1675-1690, 2005.
24. Pikarsky, E., R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli- Shoval, E. Galun and Y. Ben-Neriah. NF-KB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466, 2004. (Pubitemid 39329586)
25. Stinchcombe, T.E., C.B. Lee and M.A. Socinski. Current approaches to advance-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status. Clin. Lung Cancer Suppl. 4: S1111-S1117, 2006.
26. Suzuki, A., T. Ito, H. Kawano, M. Hayashida, Y. Hayasaki, Y. Tsutomi, K. Akahane, T. Nakano, M. Miura and K. Shiraki. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19: 1346-1353, 2000. (Pubitemid 30160627)
27. Sweeney, C, L. Li, R. Shanmugam, P. Bhat-Nakshatri, V. Jayaprakasan, LA. Baldridge, T. Gardner, M. Smith, H. Nakshatri and L. Cheng. Nuclear factor-KB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin. Cancer Res. 10: 5501-5507, 2004. (Pubitemid 39100488)
28. Thees, S., G.B. Hubbard, J. Winckler, C. Schultz and A. Rami. Specific alteration of the Bax/Bcl2 ratio and cytochrome c without execution of apoptosis in the hippocampus of aged baboons. Rest. Neurol. Neurosci. 23: 1-9, 2005. (Pubitemid 40529557)
29. Wang, C.Z., H.H. Aung, M. Ni, J.A. Wu, R. Tong, S. Wicks, T.C. He and C.S. Yuan. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 73: 669-674, 2007a. (Pubitemid 47066161)
30. Wang, C.Z., J.T. Xie, B. Zhang, M. Ni, A. Fishbein, H.H. Aung, S.R. Mehendale, W. Du, T.C. He and C.S. Yuan. Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells. Int. J. Oncol. 31: 1149-1156, 2007b.
31. Wang, W., H. Wang, E.R. Rayburn, Y. Zhao, D.L. Hill and R. Zhang. 20(S)-25-methoxyl-dam-marane-3, 12, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br. J. Cancer 98: 792-802, 2008. (Pubitemid 351272613)
32. Yang, Z.G., H.X. Sun and Y.P. Ye. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem. Biodivers. 3: 187-197, 2006.
33. Yeo, E.J., Y.C. Hwang, C.M. Kang, I.H. Kim, D.I. Kim, J.S. Parka, H.E. Choy, W.Y. Park and S.C. Park. Senescence-like changes induced by hydroxyurea in human diploid fibroblasts. Exp. Gerontol. 35: 553-571, 2000.
34. Zinkel, S., A. Gross and E. Yang. BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 13: 1351-1359, 2006. (Pubitemid 44057470)